Ticker Details
Repligen Corporation Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.
IPO Date:	March 26, 1990
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$6.49B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.23 | 2.15%
Avg Daily Range (30 D):	$3.02 | 2.52%
Avg Daily Range (90 D):	$2.76 | 2.15%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	1.08M
Avg Daily Volume (90 D):	.83M

Trade Size
Avg Trade Size (Sh.):	69
Avg Trade Size (Sh.) (30 D):	49
Avg Trade Size (Sh.) (90 D):	46

Institutional Trades
Total Institutional Trades:	6,202
Avg Institutional Trade:	$5.15M
Avg Institutional Trade (30 D):	$5.99M
Avg Institutional Trade (90 D):	$6.75M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$7.57M
Avg Closing Trade (30 D):	$15.27M
Avg Closing Trade (90 D):	$13.89M
Avg Closing Volume:	63.76K

News

Jan 20, 2026 @ 5:38 PM Single-Use Bioprocessing Market Projected to Reach... Source: Astute Analytica

Jan 16, 2026 @ 5:38 PM Continuous Bioprocessing Market Set to Surpass Val... Source: Astute Analytica

Oct 24, 2025 @ 2:00 PM Filtration in Biologics Market: Trends, Growth Dri... Source: Towards Healthcare

Feb 20, 2025 @ 4:25 PM Repligen's Q4 Slightly Tops Expectations Source: Jesterai

Jan 9, 2025 @ 12:30 AM Chromatography System Market to Reach US$ 2.62 Bil... Source: Fact.Mr

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.92	$.15	$.24
Diluted EPS	$.9	$.15	$.23
Revenue	$763.34M	$194.26M	$197.91M
Gross Profit	$403.77M	$108.28M	$103.83M
Net Income / Loss	$51.4M	$8.33M	$13.29M
Operating Income / Loss	$64.53M	$15.94M	$17.87M
Cost of Revenue	$359.57M	$85.97M	$94.08M
Net Cash Flow	$-113.37M	$18.76M	$-182.85M
PE Ratio